Therapeutic advances in melanoma

Dermatologic Clinics

Volumn 18, Issue 1, 2000, Pages 157-167

  Pitts, Jeanette M ^a   Maloney, Mary E ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBODY; BCG VACCINE; BLEOMYCIN; CARBOHYDRATE ANTIGEN; CARBOPLATIN; CARMUSTINE; CHLORMETHINE; CISPLATIN; DACARBAZINE; FOTEMUSTINE; GAMMA INTERFERON; GANGLIOSIDE; HYDROXYUREA; IMMUNOGLOBULIN ANTIBODY; INTERLEUKIN 2; KEYHOLE LIMPET HEMOCYANIN; LOMUSTINE; MELANOMA ANTIGEN; MELANOMA VACCINE; MELPHALAN; MESSENGER RNA; QS 21; TAMOXIFEN; TECHNETIUM 99M; TEMOZOLOMIDE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

BONE MARROW SUPPRESSION; BRAIN METASTASIS; CANCER STAGING; CLINICAL TRIAL; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTHERMIC THERAPY; IMMUNOTHERAPY; LIMB PERFUSION; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MELANOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033985818     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70156-X     Document Type: Article

References (99)

1. F.E. Adair Treatment of melanoma: Report of four hundred cases Surgery Gynecology and Obstetrics 62 1936 406
2. J.J. Albertini C.W. Cruse D. Rapaport Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma Ann Surg 223 1996 217
3. K.K. Ang R.M. Byers L.J. Peters Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma Arch Otolaryngol Head Neck Surg 116 1990 169 172
4. K.K. Ang F.B. Geara R.M. Byers Radiotherapy for melanoma Balch C.M. Houghton A.N. Sober AJ and Soong S. Cutaneous Melanoma 1998 JB Lippincott Philadelphia 389 403
5. K.K. Ang L.J. Peters R.S. Weber Postoperative radiotherapy for cutaneous melonoma of the head and neck region Int J Radiat Oncol Biol Phys 30 1994 795 798
6. C.M. Balch The role of elective lymph node dissection in melanoma: Rationale, results, and controversies J Clin Oncol 6 1988 163
7. C.M. Balch N. Cascinelli F.H. Sim Elective lymph node dissection: Results of prospective randomized surgical trials Balch C.M. Houghton A.N. Sober A.J. Cutaneous Melanoma ed 3 1998 Quality Medical Publishing St. Louis 210
8. C.M. Balch S. Soong A.A. Bartolucci Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger Ann Surg 224 1996 255
9. C.M. Balch S. Soong G.W. Milton A comparison of prognostic factors and surgical results in 1786 patients with localized (Stage I) melanoma treated in Alabama, USA, and New South Wales, Australia Ann Surg 196 1982 677
10. C.M. Balch M.M. Urist C.P. Karakousis Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm) Ann Surg 218 1993 262
11. S.M. Bentzen J. Overgaard H.D. Thames Clinical radiobiology of malignant melanoma Radiother Oncol 16 1989 169
12. N. Bleehen E. Newlands S. Lee Cancer Research Campaign phase II trial of temozolamide in metastatic melanoma J Clin Oncol 13 1995 310
13. O. Braun-Falco S. Lukacs H.H. Schoendinius Zur Behandlung der melanosis circumscripta praecancerose Dubreilh Hautarzt 26 1975 207 210
14. A. Breslow Tumor thickness, level of invasion and node of dissection in stage I cutaneous melanoma Ann Surg 182 1975 572
15. W.A. Brock F.L. Baker L.J. Peters The radiosensitivity of human head and neck squamous cell carcinomas in primary culture and its potential as a predictive assay of tumor radiocurability Int J Radiat Biol 56 1989 751
16. B.H. Burmeister B.M. Smithers M. Poulsen Radiation therapy for nodal disease in malignant melanoma World J Surg 19 1995 369 371
17. A.C. Buzaid A. Bedikian A.N. Houghton Systemic chemotherapy and biochemotherapy Balch C.M. Houghton A.N. Sober A.J. Cutaneous Melanoma ed 3 1998 Quality Medical Publishing St. Louis
18. N. Cascinelli A. Morabito M. Santinami Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial Lancet 351 1998 793
19. J.D. Chapman R.C. Urtasun A.J. Frank The measurement oxygenation status of individual tumors Paliwal B.R. Fowler J.F. Herbert D.E. Prediction of Response in Radiation Therapy: The Physical and Biological Basis 1989 American Institutes of Physics New York 49
20. K.N. Choi H.R. Withers M. Rotman Metastatic melanoma in brain: Rapid treatment or large dose fractions Cancer 56 1985 10
21. A.S. Coates C.I. Ingvar K. Petersen-Schaefer Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney melanoma unit from 1960 to 1991 J Am Coll Surg 180 1995 402
22. D.G. Coit Isolation limb perfusion for melanoma: Current trends and future directions Melanoma Res 4 1994 57
23. J.S. Cooper The evolution of the role of radiation therapy in the management of mucocutaneous malignant melanoma Hematol Oncol Clin North Am 12 1998 849 862
24. J. Costanzi M. Al-Sarraf C. Groppe Combination chemotherapy plus BCG in the treatment of disseminated malignant melanoma: A Southwest Oncology Group study Med Pediatr Oncol 10 1982 251
25. E.T. Creagan R.E. Cupps J.C. Ivins Adjuvant radiation therapy for regional nodal metastases from malignant melanoma: A randomized, prospective study Cancer 42 1978 2206
26. O. Creech E.T. Krementz R.F. Ryan Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit Ann Surg 148 1958 616
27. De Groot W.P. Provisional results of treatment of precancereuse circonscrite Dubreuilh by Bucky-rays Dermotologica 136 1968 429 431
28. M.J. Edwards S. Soong A.W. Boddie Isolated limb perfusion for localized melanoma of the extremity Arch Surg 125 1990 317
29. D.E. Elder D. Guerry M. VanHorn The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51–3.99 mm) Cancer 56 1985 f413
30. F. Ellis The radiosensitivity of malignant melanomata Br J Radiol 12 1939 327
31. C.I. Falkson J. Ibrahim J. Kirkwood Phase III trial of dacarbazine versus decarbazine with interferon alfa-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: An Eastern Cooperative Oncology Group study J Clin Oncol 16 1998 1743
32. H.J. Fee D.S. Robinson W.F. Sample The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: A preliminary study Surgery 84 1978 626
33. D.L. Fraker Hyperthermic regional perfusion for melanoma of the limbs Balch C.M. Houghton A.N. Sober A.J. Cutaneous Melanoma ed 3 1998 Quality Medical Publishing St. Louis 281
34. J.E. Gershenwald M.I. Colome J.E. Lee Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma J Clin Oncol 16 1998 2253
35. J.E. Gershenwald C. Tseng W. Thompson Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid Surgery 124 1998 203
36. R.J. Green L.M. Schuchter Systemic treatment of metastatic melanoma with chemotherapy Hematol Oncol Clin North 12 1998 863
37. Hafstrom L. Rudenstam C.-M. E. Blomquist Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group J Clin Oncol 9 1991 2091
38. H.J. Habermalz J.J. Fischer Radiation therapy of malignant melanoma Cancer 38 1976 2258 2262
39. A.R. Harwood Conventional fractionated radiotherapy for 31 patients with lentigo maligna and lentigo maligna melanoma Int J Radiat Oncol Biol Phys 9 1983 1019 1021
40. A.R. Harwood Radiation therapy of stage I and II disease Miller S.J. Maloney M.E. Cutaneous Oncology 1998 Blackwell Science 316 322
41. A.R. Harwood S.P. Stringer R.R. Million Melanoma of the head and neck Million R.R. Cassisi N.J. Management of Head and Neck Cancer 1994 JB Lippincott Philadelphia 693
42. W. Hellriegel Radiation therapy of primary and metastatic melanoma Ann NY Acad Sci 100 1963 131 141
43. T. Hietanen S. Nieminen T. Ekfors Elective treatment of regional lymph nodes in malignant melanoma Strahlentherapie 161 1985 1 4
44. G.I.I. Hill E. Krementz H. Hill Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma. IV. Late results after complete response to chemotherapy. Central Oncology Group Protocols 7130, 7131, and 7131A Cancer 53 1984 1299
45. E.C. Holmes H.S. Moseley D.L. Morton A rational approach to the surgical management of melanoma Ann Surg 186 1977 481
46. S. Hornsey The relationship between total dose, number of fractions and fraction size in the response of malignant melanoma in patients Br J Radiol 51 1978 905 909
47. C. Jacquillat D. Khayat P. Banzet Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases Cancer 66 1990 1873
48. P.C. Jones L.L. Sze P.Y. Liu Prolonged survival for melanoma patients with elevated IgM Antibody to oncofetal antigen J Natl Cancer Inst 66 1981 249
49. D. Khayat B. Giroux J. Berille Fotemustine in the treatment of brain primary tumors and metastases Cancer Invest 12 1994 414
50. S.H. Kim D.G. Coit Surgical treatment of stage I and II disease (excision, lymphadenectomy, limb perfusion) Miller S.J. Maloney M.E. Cutaneous Oncology 1998 Blackwell Science Malden 303
51. J.M. Klaase B.B.R. Kroon A.M.M. Eggermount A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities Eur J Cancer 31A 1995 58
52. A.W. Kopf R.S. Bart A.H. Cladstein Treatment of melanotic freckle with x-rays Arch Dermatol 112 1976 801 807
53. E.T. Krementz R.D. Carter C.M. Sutherland The use of regional chemotherapy in the management of malignant melanoma World J Surg 3 1979 289
54. Lee SM, Betticher DC, Thatcher N: Melanoma: Chemotherapy. Br Med Bull 51:609
55. S.S. Legha R. Sigrid O. Eton Development and results of biochemotherapy in metastatic melanoma: The University of Texas M.D. Anderson Cancer Center Experience Cancer J Sci Am 3 1997 S9 S15
56. D. Lienard A.M. Eggermont H. Schraffordt Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-α), interferon-gamma (INF-γ) and melphalan for melanoma stage III. Results of a multi-centre pilot study Melanoma Res 4 1994 21
57. P.O. Livingston S. Adluri F. Helling Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma Vaccine 12 1994 1275
58. P. Livingston M. Sznol Vaccine Therapy Blach C.M. Houghton A.N. Sober A.J. Cutaneous Melanoma ed 3 1998 Quality Medical Publishing St. Louis 437
59. P.O. Livingston G.Y.C. Wong S. Adluri Improved survival in stage III melanoma patients with GM2 antibodies: A randomized trial of adjuvant vaccination with GM2 ganglioside J Clin Oncol 12 1994 1036
60. P. Livingston S. Zhang S. Adluri Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies Cancer Immunol Immunother 43 1997 324
61. P.A. Lobo E.J. Liebner J.J. Chao Radiotherapy in the management of malignant melanoma Int J Radiat Oncol Biol Phys 7 1981 21 26
62. S. Madajewicz C. Karakousis C.R. West Malignant melanoma brain metastases, review of Roswell Park Memorial Institute experience Cancer 53 1984 2550
63. D.L. Morton D. Wen L.J. Foshag Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck J Clin Oncol 11 1993 1751
64. D.L. Morton D. Wen J.H. Wong Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 1992 392
65. J. Overgaard Radiation treatment of malignant melanoma Int J Radiat Oncol Biol Phys 6 1980 41 44
66. J. Overgaard M. Overgaard Vejby Hansen P. Some factors of importance in the radiation treatment of malignant melanoma Radiother Oncol 5 1986 183
67. Overgaard J. Von Der Maase H. M. Overgaard A randomized study comparing two high-dose-per-fraction radiation schedules in recurrent or metastatic malignant melanoma Int J Radiat Oncol Biol Phys 11 1985 1837 1839
68. R.G. Panizzon Radiotherapy of lentigo maligna and lentigo maligna melanoma Orfanos C.E. Stadle R. Gollnick H. Dermatology in Five Continents 1987 Springer Verlag Berlin 930 932
69. R.G. Panizzon Die Röntgentherapie maligne Hauttumoren Ther Umsch 50 1993 835 840
70. R. Paterson Classification of tumours in relation to radiosensitivity Br J Radiol 6 1933 218
71. R. Paterson The Treatment of Malignant Disease by Radium and X-Rays 1949 Arnold London
72. L.J. Peters R.M. Byers K.K. Ang Radiotherapy for melanoma Balch C.M. Houghton A.N. Milton G.W. Cutaneous Melanoma 1992 JB Lippincott Philadelphia 509 521
73. S. Pyrhönen M. Hahka-Kempinnen T. Muhonen A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma J Clin Oncol 10 1993 1919
74. S.O. Pyrhönen M.J. Kajanti The use of large fractions in radiotherapy for malignant melanoma Radiother Oncol 24 1992 195 197
75. D.S. Reintgen E.B. Cox K.S. McCarty Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma Ann Surg 198 1983 379
76. D. Reintgen C.W. Cruse K. Wells The orderly progression of melanoma nodal metastases Ann Surg 220 1994 759
77. D.S. Reintgen D.P. Rapaport K.K. Tanabe Lymphatic mapping and sentinel lymphadenectomy Balch C.M. Houghton A.N. Sober A.J. Cutaneous Melanomas ed. 3 1998 Quality Medical Publishing St. Louis 227
78. Rofstad E.K. Influence of cellular radiation sensitivity on local tumor control of human melanoma xenografts given fractionated radiation treatment Cancer Res 51 1991 4609
79. E.K. Rofstad Human tumour xenografts in radiotherapeutic research Radiother Oncol 3 1985 35
80. E.K. Rofstad Radiation biology of malignant melanoma: Review article Acta Radiol Oncol 25 1986 1
81. E.K. Rofstad Radiation sensitivity in vitro of primary tumors and metastatic lesions of malignant melanoma Cancer Res 52 1992 4453
82. E.K. Rofstad Retention of cellular radiation sensitivity in cell and xenograft lines established from human melanoma surgical specimens Cancer Res 52 1992 1764
83. E.K. Rofstad T. Brustad Radioresponsiveness of human melanoma xenografts given fractionated irradiation in vivo–Relationship to the initial slope of the cell survival curves in vitro Radiother Oncol 9 1987 45
84. E.K. Rofstad A. Wahl T. Brustad Radiation response of multicellular spheroids initiated from five human melanoma xenograft lines. Relationship to the radioresponsiveness in vivo Br J Radiol 59 1986 1023
85. M.I. Ross C.M. Balch Surgical treatment of primary melanoma Balch C.M. Houghton A.N. Sober A.J. Cutaneous Melanoma ed 3 1998 Quality Medical Publishing St. Louis 141
86. M. Ross J.L. Meyer Management of the regional lymph nodes in malignant melanoma: Surgery, radiotherapy or observation Front Radiat Ther Oncol 28 1994 226 234
87. M.C. Rounsaville S.T. Cantril J. Fontanesi Radiotherapy in the management of cutaneous melanoma: Effect of time, dose and fractionation Front Radiat Ther Oncol 22 1998 62 78
88. F.H. Sim W.F. Taylor D.J. Pritchard Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study Mayo Clin Proc 61 1986 697
89. G. Stoter S. Aamdal S. Rodenhuis Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: A multicenter phase II study J Clin Oncol 9 1991 1687
90. J.F. Thompson J.A. Hunt K.F. Shannon Frequency and duration of remission after isolated limb perfusion for melanoma Arch Surg 132 1997 903
91. M.C. Tod Radiological treatment of malginant melanoma Br J Radiol 19 1946 223 229
92. Trott K.R. von Lieven H. J. Kummermehr The radiosensitivity of malignant melanomas, part II: Clinical studies Int J Radiat Oncol Biol Phys 7 1981 15 20
93. R.W. Tsang W. Wells D.G. Payne Lentigo maligna of the head and neck Arch Dermotol 130 1994 1008 1012
94. U. Veronesi J. Adamus D.C. Bandiera Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities Cancer 49 1982 2420
95. U. Veronesi J. Adamus D. Bandiera Inefficacy of immediate node dissection in stage I melanoma of the limbs N Engl J Med 297 1977 627
96. U. Veronesi N. Cascinelli Narrow excision (1-cm margin): A safe procedure for thin cutaneous melanoma Arch Surg 126 1991 438
97. B.C. Vrouenraets O.E. Nieweg B.B. Kroon Thirty-five years of isolated limb perfusion for melanoma: Indications and results Br J Surg 83 1996 1319
98. J.D. Wolchok P.O. Livingston A.N. Houghton Vaccines and other adjuvant therapies for melanoma Hematol Oncol Clin North Am 12 1998 835
99. J.C. Ziegler J.S. Cooper Brain metastases from malignant melanoma: Conventional vs. high-dose-per fraction radiotherapy Int J Radiat Oncol Biol Phys 12 1986 1839